The FDA just approved another new drug that could save the US billions — but there’s a catch
|09/23/2016||Posted by BusinessMediaguide.Com under General World News||
The FDA just approved a version of Humira, the blockbuster arthritis drug made by AbbVie that brought in $14 billion in sales in 2015.
The drug, called Amjevita (adalimumab-atto), is a “biosimilar,” which is like a generic version of a biologic medication, a medicine produced by living cells.
Biosimilars are a bit more complicated than your average competing medicine: Unlike generics for chemical-based drugs like antibiotics, which can be interchangeable with branded versions, the copycats of biologic medications have a few more caveats.